Page last updated: 2024-10-25

ciglitazone and Pre-Eclampsia

ciglitazone has been researched along with Pre-Eclampsia in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Meister, S1
Hahn, L1
Beyer, S1
Paul, C1
Mitter, S1
Kuhn, C1
von Schönfeldt, V1
Corradini, S1
Sudan, K1
Schulz, C1
Kolben, TM1
Mahner, S1
Jeschke, U1
Kolben, T1

Other Studies

1 other study available for ciglitazone and Pre-Eclampsia

ArticleYear
Regulation of Epigenetic Modifications in the Placenta during Preeclampsia: PPARγ Influences H3K4me3 and H3K9ac in Extravillous Trophoblast Cells.
    International journal of molecular sciences, 2021, Nov-18, Volume: 22, Issue:22

    Topics: Adult; Benzamides; Case-Control Studies; Epigenesis, Genetic; Female; Histones; Humans; Methylation;

2021